Towa Pharmaceutical Co., Ltd. (4553.T)
JPY 2808.0
(2.3%)
JPY 2808.0
(2.3%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 274.75 Billion JPY | 17.19% |
| 2022 | 234.45 Billion JPY | 18.55% |
| 2021 | 197.76 Billion JPY | 53.22% |
| 2020 | 129.07 Billion JPY | 4.52% |
| 2019 | 123.49 Billion JPY | 27.26% |
| 2018 | 97.03 Billion JPY | -0.38% |
| 2017 | 97.4 Billion JPY | 7.87% |
| 2016 | 90.3 Billion JPY | 4.7% |
| 2015 | 86.24 Billion JPY | 68.65% |
| 2014 | 51.14 Billion JPY | 18.46% |
| 2013 | 43.17 Billion JPY | 26.62% |
| 2012 | 34.09 Billion JPY | 10.88% |
| 2011 | 30.75 Billion JPY | 16.92% |
| 2010 | 26.3 Billion JPY | 41.71% |
| 2009 | 18.55 Billion JPY | 82.08% |
| 2008 | 10.19 Billion JPY | 0.64% |
| 2007 | 10.12 Billion JPY | -2.59% |
| 2006 | 10.39 Billion JPY | 15.79% |
| 2005 | 8.98 Billion JPY | -10.87% |
| 2004 | 10.07 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 288.23 Billion JPY | 4.91% |
| 2023 Q4 | 274.75 Billion JPY | 3.34% |
| 2023 Q3 | 265.86 Billion JPY | 8.05% |
| 2023 FY | 274.75 Billion JPY | 17.19% |
| 2023 Q2 | 246.05 Billion JPY | -1.65% |
| 2023 Q1 | 250.17 Billion JPY | 6.71% |
| 2022 Q2 | 212.92 Billion JPY | 9.85% |
| 2022 Q3 | 219.56 Billion JPY | 3.12% |
| 2022 Q4 | 234.45 Billion JPY | 6.78% |
| 2022 FY | 234.45 Billion JPY | 18.55% |
| 2022 Q1 | 193.82 Billion JPY | -1.99% |
| 2021 Q2 | 126.49 Billion JPY | -0.46% |
| 2021 Q1 | 127.07 Billion JPY | -1.54% |
| 2021 FY | 197.76 Billion JPY | 53.22% |
| 2021 Q4 | 197.76 Billion JPY | 57.75% |
| 2021 Q3 | 125.37 Billion JPY | -0.89% |
| 2020 FY | 129.07 Billion JPY | 4.52% |
| 2020 Q1 | 139.19 Billion JPY | 12.72% |
| 2020 Q2 | 128.37 Billion JPY | -7.77% |
| 2020 Q3 | 125.93 Billion JPY | -1.9% |
| 2020 Q4 | 129.07 Billion JPY | 2.49% |
| 2019 FY | 123.49 Billion JPY | 27.26% |
| 2019 Q4 | 123.49 Billion JPY | 33.23% |
| 2019 Q3 | 92.68 Billion JPY | -1.86% |
| 2019 Q2 | 94.44 Billion JPY | 0.16% |
| 2019 Q1 | 94.29 Billion JPY | -2.82% |
| 2018 Q3 | 90.9 Billion JPY | 0.17% |
| 2018 Q4 | 97.03 Billion JPY | 6.74% |
| 2018 FY | 97.03 Billion JPY | -0.38% |
| 2018 Q1 | 91.51 Billion JPY | -6.04% |
| 2018 Q2 | 90.75 Billion JPY | -0.84% |
| 2017 Q1 | 90.35 Billion JPY | 0.06% |
| 2017 FY | 97.4 Billion JPY | 7.87% |
| 2017 Q4 | 97.4 Billion JPY | 0.97% |
| 2017 Q3 | 96.47 Billion JPY | 4.1% |
| 2017 Q2 | 92.67 Billion JPY | 2.56% |
| 2016 Q3 | 90.94 Billion JPY | -1.66% |
| 2016 FY | 90.3 Billion JPY | 4.7% |
| 2016 Q1 | 86.32 Billion JPY | 0.09% |
| 2016 Q4 | 90.3 Billion JPY | -0.71% |
| 2016 Q2 | 92.48 Billion JPY | 7.14% |
| 2015 Q1 | 58.29 Billion JPY | 13.99% |
| 2015 Q2 | 76.08 Billion JPY | 30.53% |
| 2015 Q3 | 76.91 Billion JPY | 1.09% |
| 2015 Q4 | 86.24 Billion JPY | 12.13% |
| 2015 FY | 86.24 Billion JPY | 68.65% |
| 2014 Q4 | 51.14 Billion JPY | 7.25% |
| 2014 Q3 | 47.68 Billion JPY | 13.88% |
| 2014 Q2 | 41.87 Billion JPY | 4.3% |
| 2014 FY | 51.14 Billion JPY | 18.46% |
| 2014 Q1 | 40.14 Billion JPY | -7.0% |
| 2013 Q2 | 31.52 Billion JPY | -2.8% |
| 2013 FY | 43.17 Billion JPY | 26.62% |
| 2013 Q3 | 38.34 Billion JPY | 21.64% |
| 2013 Q4 | 43.17 Billion JPY | 12.59% |
| 2013 Q1 | 32.43 Billion JPY | -4.89% |
| 2012 FY | 34.09 Billion JPY | 10.88% |
| 2012 Q4 | 34.09 Billion JPY | 7.67% |
| 2012 Q3 | 31.66 Billion JPY | -5.58% |
| 2012 Q2 | 33.54 Billion JPY | -2.3% |
| 2012 Q1 | 34.33 Billion JPY | 11.64% |
| 2011 FY | 30.75 Billion JPY | 16.92% |
| 2011 Q2 | 27.11 Billion JPY | 2.35% |
| 2011 Q3 | 29.49 Billion JPY | 8.78% |
| 2011 Q1 | 26.49 Billion JPY | 0.73% |
| 2011 Q4 | 30.75 Billion JPY | 4.25% |
| 2010 Q1 | 16.51 Billion JPY | -11.03% |
| 2010 Q4 | 26.3 Billion JPY | 6.66% |
| 2010 FY | 26.3 Billion JPY | 41.71% |
| 2010 Q2 | 21.35 Billion JPY | 29.35% |
| 2010 Q3 | 24.65 Billion JPY | 15.45% |
| 2009 FY | 18.55 Billion JPY | 82.08% |
| 2009 Q2 | 13.81 Billion JPY | 52.24% |
| 2009 Q3 | 14.54 Billion JPY | 5.31% |
| 2009 Q4 | 18.55 Billion JPY | 27.58% |
| 2009 Q1 | 9.07 Billion JPY | -10.98% |
| 2008 Q4 | 10.19 Billion JPY | 18.0% |
| 2008 FY | 10.19 Billion JPY | 0.64% |
| 2008 Q3 | 8.63 Billion JPY | 0.0% |
| 2007 FY | 10.12 Billion JPY | -2.59% |
| 2006 FY | 10.39 Billion JPY | 15.79% |
| 2005 FY | 8.98 Billion JPY | -10.87% |
| 2004 FY | 10.07 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -999.56% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 96.493% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 63.432% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | -67.175% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -7993.069% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -540.94% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -885.997% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 44.474% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -5351.548% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | -345.356% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -791.146% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -590.451% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -783.921% |
| Tsumura & Co. | 132.88 Billion JPY | -106.762% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -590.503% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -1966.316% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -522.216% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | -288.599% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | -485.925% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -3823.433% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -980.066% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -3274.52% |
| MedRx Co., Ltd | 129 Million JPY | -212890.698% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -8295.877% |
| Solasia Pharma K.K. | 673 Million JPY | -40725.854% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -42464.945% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -775.555% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | -67.541% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -27067.718% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 47.564% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -3852.022% |